Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021. https://doi.org/10.1002/ijc.33588.

Article  PubMed  Google Scholar 

Canadian Cancer Statistics Advisory Committee. Canadian cancer statistics: a 2020 special report on lung cancer. Toronto. 2020.

Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society SC and the PHA of C. Canadian Cancer Statistics 2021. Toronto. 2021.

Statistics Canada. Number and rates of new cases of primary cancer, by cancer type, age group and sex 2022. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310011101. Accessed 19 July 2022.

de Oliveira C, Bremner KE, Pataky R, Gunraj N, Chan K, Peacock S, et al. Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study. CMAJ Open. 2013;1:E1-8. https://doi.org/10.9778/cmajo.20120013.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Cancer 2022. https://www.who.int/health-topics/cancer#tab=tab_1. Accessed 19 July 2022.

International Agency for Research on Cancer. Cancer fact sheets. Global Cancer Observatory 2020.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. https://doi.org/10.3322/caac.21590.

Article  PubMed  Google Scholar 

Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 1979;2018(359):926–30.

Google Scholar 

Kwong GA, Ghosh S, Gamboa L, Patriotis C, Srivastava S, Bhatia SN. Synthetic biomarkers: a twenty-first century path to early cancer detection. Nat Rev Cancer. 2021;21:655–68. https://doi.org/10.1038/s41568-021-00389-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

International Agency for Research on Cancer. What is an “organized” screening programme? European Code against Cancer: 12 Ways to Reduce Your Cancer Risk.

Bozic I, Reiter JG, Allen B, Antal T, Chatterjee K, Shah P, et al. Evolutionary dynamics of cancer in response to targeted combination therapy. Elife. 2013. https://doi.org/10.7554/eLife.00747.

Article  PubMed  PubMed Central  Google Scholar 

Moertel CG. Fluorouracil plus Levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med. 1995;122:321. https://doi.org/10.7326/0003-4819-122-5-199503010-00001.

Article  CAS  PubMed  Google Scholar 

Huang D, Pastagia M, Ericsson C. Issues for travelers. In: Tyring S, Lupi O, Hengge U, editors. Tropical dermatology. 2nd ed. Elsevier; 2017. p. 14–22.

Chapter  Google Scholar 

Ahlquist DA. Universal cancer screening: revolutionary, rational, and realizable. NPJ Precis Oncol. 2018. https://doi.org/10.1038/s41698-018-0066-x.

Article  PubMed  PubMed Central  Google Scholar 

Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, CCGA Consortium. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020;31:745–59. https://doi.org/10.1016/j.annonc.2020.02.011.

Article  CAS  PubMed  Google Scholar 

Jiao B, Gulati R, Katki HA, Castle PE, Etzioni R. A quantitative framework to study potential benefits and harms of multi-cancer early detection testing. Cancer Epidemiol Biomark Prev. 2022;31:38–44. https://doi.org/10.1158/1055-9965.EPI-21-0380.

Article  Google Scholar 

Kisiel JB, Papadopoulos N, Liu MC, Crosby D, Srivastava S, Hawk ET. Multicancer early detection test: Preclinical, translational, and clinical evidence–generation plan and provocative questions. Cancer. 2022;128:861–74. https://doi.org/10.1002/cncr.33912.

Article  CAS  PubMed  Google Scholar 

Cherla A, Renwick M, Jha A, Mossialos E. Cost-effectiveness of cancer drugs: comparative analysis of the United States and England. EClinicalMedicine. 2020;29–30: 100625. https://doi.org/10.1016/j.eclinm.2020.100625.

Article  PubMed  PubMed Central  Google Scholar 

Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J. 1992;146:473–81. https://doi.org/10.1023/a:1015837113683.

Article  CAS  Google Scholar 

Telford JJ, Levy AR, Sambrook JC, Zou D, Enns RA. The cost-effectiveness of screening for colorectal cancer. CMAJ. 2010;182:1307–13. https://doi.org/10.1503/cmaj.090845.

Article  PubMed  PubMed Central  Google Scholar 

Song SY, Park B, Hong S, Kim MJ, Lee EH, Jun JK. Comparison of digital and screen-film mammography for breast cancer screening: a systematic review and meta-analysis. J Breast Cancer. 2019;22:311. https://doi.org/10.4048/jbc.2019.22.e24.

Article  PubMed  PubMed Central  Google Scholar 

Kalyta A, De Vera MA, Peacock S, Telford JJ, Brown CJ, Donnellan F, et al. Canadian colorectal cancer screening guidelines: Do they need an update given changing incidence and global practice patterns? Curr Oncol. 2021;28:1558–70. https://doi.org/10.3390/curroncol28030147.

Article  PubMed  PubMed Central  Google Scholar 

National Cancer Institute. Dictionary of cancer terms.

American Cancer Society. Cancer surveillance programs in the United States.

Brouwers MC, De Vito C, Bahirathan L, Carol A, Carroll JC, Cotterchio M, et al. What implementation interventions increase cancer screening rates? A systematic review. Implement Sci. 2011. https://doi.org/10.1186/1748-5908-6-111.

Article  PubMed  PubMed Central  Google Scholar 

Siu AL, U.S. Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164:279–96. https://doi.org/10.7326/M15-2886.

Article  PubMed  Google Scholar 

Jørgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29–32. https://doi.org/10.1136/gut.50.1.29.

Article  PubMed  PubMed Central  Google Scholar 

Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7. https://doi.org/10.1056/NEJM199203053261001.

Article  CAS  PubMed  Google Scholar 

Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–71. https://doi.org/10.1056/NEJM199305133281901.

Article  CAS  PubMed  Google Scholar 

Surveillance Research Program NCI. SEER*Explorer: An interactive website for SEER cancer statistics [Internet] n.d. https://seer.cancer.gov/statistics-network/explorer/. Accessed 3 Dec 2022.

CADTH. Guidelines for the economic evaluation of health technologies: Canada 4th edition CADTH methods and guidelines service line. Ottawa. 2017.

Statistics Canada. Table 13-10-0837-01 Life expectancy and other elements of the complete life table, single-year estimates, Canada, all provinces except Prince Edward Island. 2022. https://doi.org/10.25318/1310083701-eng.

Baratella E, Cernic S, Minelli P, Furlan G, Crimì F, Rocco S, et al. Accuracy of CT-guided core-needle biopsy in diagnosis of thoracic lesions suspicious for primitive malignancy of the lung: a five-year retrospective analysis. Tomography. 2022;8:2828–38. https://doi.org/10.3390/tomography8060236.

Article  PubMed  PubMed Central  Google Scholar 

Bloomfeld RS, Bridgers DI, Pineau BC. Sensitivity of upper endoscopy in diagnosing esophageal cancer. Dysphagia. 2005;20:278–82. https://doi.org/10.1007/s00455-005-0025-x.

Article  PubMed  Google Scholar 

Jiang K, Jiang X, Pan J, Wen Y, Huang Y, Weng S, et al. Current evidence and future perspective of accuracy of artificial intelligence application for early gastric cancer diagnosis with endoscopy: a systematic and meta-analysis. Front Med (Lausanne). 2021;8: 629080. https://doi.org/10.3389/fmed.2021.629080.

Article  PubMed  Google Scholar 

Nadarevic T, Giljaca V, Colli A, Fraquelli M, Casazza G, Miletic D, et al. Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev. 2021. https://doi.org/10.1002/14651858.CD013362.pub2.

Article  PubMed  PubMed Central  Google Scholar 

Dabizzi E, Assef MS, Raimondo M. Diagnostic management of pancreatic cancer. Cancers (Basel). 2011;3:494–509. https://doi.org/10.3390/cancers3010494.

Article  PubMed  Google Scholar 

Menon U, McGuire AJ, Raikou M, Ryan A, Davies SK, Burnell M, et al. The cost-effectiveness of screening for ovarian cancer: Results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Br J Cancer. 2017;117:619–27. https://doi.org/10.1038/bjc.2017.222.

Article  PubMed  PubMed Central  Google Scholar 

Breast Cancer Surveillance Consortium. Diagnostic mammography, sensitivity, specificity & false negative rate n.d. https://www.bcsc-research.org/statistics/diagnostic-performance-benchmarks/diagnostic-mammography-sensitivity-specificity. Accessed 4 Dec 2022.

Statistics Canada. Table 18-10-0004-01 Consumer Price Index, monthly, not seasonally adjusted. 2022. https://doi.org/10.25318/1810000401-eng.

de Oliveira C, Pataky R, Bremner KE, Rangrej J, Chan KKW, Cheung WY, et al. Phase-specific and lifetime costs of cancer care in Ontario, Canada. BMC Cancer. 2016;16:809. https://doi.org/10.1186/s12885-016-2835-7.

Article  PubMed  PubMed Central  Google Scholar 

Pourrahmat M-M, Kim A, Kansal AR, Hux M, Pushkarna D, Fazeli MS, et al. Health state utility values by cancer stage: a systematic literature review. Eur J Health Econ. 2021;22:1275–88. https://doi.org/10.1007/s10198-021-01335-8.

Article  PubMed  PubMed Central  Google Scholar 

Havrilesky LJ, Maxwell GL, Myers ER. Cost-effectiveness analysis of annual screening strategies for endometrial cancer. Am J Obstet Gynecol. 2009;200:640.e1-640.e8. https://doi.org/10.1016/j.ajog.2009.02.022.

Article  PubMed  Google Scholar 

Lee H-J, Ock M, Kim K, Jo M-W. Estimation of population-based utility weights for gastric cancer-related health states. Patient Prefer Adherence. 2018;12:909–18. https://doi.org/10.2147/PPA.S151946.

Article  PubMed